NDC 67871-111

Sucraid

Sacrosidase

Sucraid is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Qol Medical, Llc. The primary component is Sacrosidase.

Product ID67871-111_08442b45-329a-4e4d-8387-7a5698e96cd7
NDC67871-111
Product TypeHuman Prescription Drug
Proprietary NameSucraid
Generic NameSacrosidase
Dosage FormSolution
Route of AdministrationORAL
Marketing Start Date1998-04-09
Marketing CategoryBLA / NDA
Application NumberBLA020772
Labeler NameQOL Medical, LLC
Substance NameSACROSIDASE
Active Ingredient Strength8500 [iU]/mL
Pharm ClassesSucrose-specific Enzyme [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 67871-111-04

2 BOTTLE in 1 CARTON (67871-111-04) > 118 mL in 1 BOTTLE (67871-111-01)
Marketing Start Date1998-04-09
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 67871-111-01 [67871011101]

Sucraid SOLUTION
Marketing CategoryBLA
Application NumberBLA020772
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1998-04-09

NDC 67871-111-04 [67871011104]

Sucraid SOLUTION
Marketing CategoryBLA
Application NumberBLA020772
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1998-04-09
Inactivation Date2020-01-31
Reactivation Date2020-04-15

Drug Details

Active Ingredients

IngredientStrength
SACROSIDASE8500 [iU]/mL

OpenFDA Data

SPL SET ID:d613bb7f-c3f4-462e-81a2-da2347cc4b6b
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 213337
  • 312872
  • Pharmacological Class

    • Sucrose-specific Enzyme [EPC]

    Trademark Results [Sucraid]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    SUCRAID
    SUCRAID
    75103897 2198812 Live/Registered
    QOL MEDICAL LLC
    1996-05-14

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.